开发基于碳的新型生物医学平台,用于干预异种毒剂诱导的帕金森病发病
Jyotish Kumar1, Armando Varela-Ramirez2, Mahesh Narayan1
1Department of Chemistry and Biochemistry, The University of Texas at El Paso (UTEP), El Paso, USA.
BMEmat
|April 23, 2025
概括
来自植物酸的绿色合成碳量子点可以防止农药诱导的神经退行. 这些生物相容纳米材料在预防帕金森病方面表现有前途.
科学领域:
- 纳米材料科学 科学 纳米材料科学
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 长期接触农药与神经退行性疾病,如帕金森病 (PD) 有关.
- 环境神经毒剂,如帕拉克瓦特,与PD病变发生有关.
- 开发有效的神经保护剂对于对抗神经退行性疾病至关重要.
研究的目的:
- 调查酸和酸衍生碳量子点 (QACQD和ChACQD) 对抗帕奎特诱导的神经毒性的神经保护潜力.
- 评估QACQDs和ChACQDs防止粉样蛋白形成蛋白质聚合的能力.
- 评估这些CQD在细胞和模型生物中的生物相容性和有效性.
主要方法:
- 使用绿色化学方法合成QACQD和ChACQD.
- 在体外研究中,使用蛋白色酶 (HEWL) 来评估蛋白质聚合抑制.
- 使用人类神经母细胞瘤细胞 (SH-SY5Y) 进行体外研究,以评估生物相容性和对帕拉克瓦特的保护.
- 在体内研究使用线虫*C. elegans*作为帕拉克瓦特诱导的多巴胺基神经退行症的模型.
主要成果:
- QACQDs和ChACQDs抑制了HEWL转化为有毒聚合物的过程.
- 这两种CQD都表现出抗氧化活性,并且与SH-SY5Y细胞生物相容,最高可达5mg/ml.
- QACQD和ChACQD保护了SH-SY5Y细胞免受帕拉克瓦特诱导的毒性.
- 在帕金森病的*C. elegans*模型中,CQDs证明了对帕拉克瓦特的神经保护.
结论:
- 来自植物的QACQD和ChACQD具有重要的神经保护性质,可以防止农药引起的损伤.
- 这些CQD具有生物相容性,可以抑制蛋白质聚合,这是神经退行性疾病的关键因素.
- 它们穿越血脑屏障的能力使得它们成为开发针对神经退行性疾病的新型治疗策略的有希望的候选人.
相关概念视频
01:24Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
01:15Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
01:21EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K